NEOGENOMICS INC — Director's Dealing 2025

Jun 24, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-06-19

Reporting Person: Green Marjorie C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-19	Stock Option (Right to Buy)	$6.95	A	16019	Acquired	2035-06-19	Common Stock (16019)	Direct
2025-06-19	Restricted Stock Unit	$0	A	22964	Acquired		Common Stock (22964)	Direct

Footnotes

F1: Once vested, the shares of common stock are not subject to expiration.